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Abstract
Background: Vital signs monitoring is a universal tool for the detection of postoperative complications; however, unwell
patients can be missed between traditional observation rounds. New remote monitoring technologies promise to convey the
benefits of continuous monitoring to patients in general wards.
Objective: The aim of this pilot study was to evaluate whether continuous remote vital signs monitoring is a practical and
acceptable way of monitoring surgical patients and to optimize the delivery of a definitive trial.
Methods: We performed a prospective, cluster-randomized, parallel-group, unblinded, controlled pilot study. Patients admitted
to 2 surgical wards at a large tertiary hospital received either continuous and intermittent vital signs monitoring or intermittent
monitoring alone using an early warning score system. Continuous monitoring was provided by a wireless patch, worn on the
patient’s chest, with data transmitted wirelessly every 2 minutes to a central monitoring station or a mobile device carried by the
patient’s nurse. The primary outcome measure was time to administration of antibiotics in sepsis. The secondary outcome measures
included the length of hospital stay, 30-day readmission rate, mortality, and patient acceptability.
Results: Overall, 226 patients were randomized between January and June 2017. Of 226 patients, 140 were randomized to
continuous remote monitoring and 86 to intermittent monitoring alone. On average, patients receiving continuous monitoring
were administered antibiotics faster after evidence of sepsis (626 minutes, n=22, 95% CI 431.7-820.3 minutes vs 1012.8 minutes,
n=12, 95% CI 425.0-1600.6 minutes), had a shorter average length of hospital stay (13.3 days, 95% CI 11.3-15.3 days vs 14.6
days, 95% CI 11.5-17.7 days), and were less likely to require readmission within 30 days of discharge (11.4%, 95% CI 6.16-16.7
vs 20.9%, 95% CI 12.3-29.5). Wide CIs suggest these differences are not statistically significant. Patients found the monitoring
device to be acceptable in terms of comfort and perceived an enhanced sense of safety, despite 24% discontinuing the intervention
early.
Conclusions: Remote continuous vital signs monitoring on surgical wards is practical and acceptable to patients. Large,
well-controlled studies in high-risk populations are required to determine whether the observed trends translate into a significant
benefit for continuous over intermittent monitoring.
Trial Registration: International Standard Randomised Controlled Trial Number ISRCTN60999823; http://www.isrctn.com
/ISRCTN60999823 (Archived by WebCite at http://www.webcitation.org/73ikP6OQz)
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Introduction
Perioperative complications are unfortunately common
following surgical procedures. Postoperative mortality is the
third leading cause of death in the United States [1]. The
International Surgical Outcomes Study found that 17% of
patients undergoing inpatient surgery developed at least one
complication [2]. This figure rose to 27% in patients undergoing
major surgery. In addition, 2.8% of patients who developed a
postoperative complication died before discharge from hospital.
Monitoring patients beyond the operating room is important to
allow early detection of clinical deterioration and timely
intervention [3].
The early warning score system is predicated on the idea that
derangements in simple physiological observations can identify
hospital inpatients at high risk of deterioration [4]. Prodromal
warning signs, such as increased respiratory rate or decreased
blood pressure, precede critical illness [5], allowing early
recognition and management of patients to reverse the abnormal
physiological decline or prompt admission to a critical care area.
A critical limitation of early warning score systems is their
intermittent nature [6]. Clinical deterioration on general wards
may remain undetected for hours before clinicians are alerted
[3]. One solution may be continuous vital signs monitoring,
which until now has been limited to use on critical care wards
owing to prohibitive cost and implications for patient mobility
and recovery.
The development of wireless and wearable sensors allows
continuous monitoring of ambulatory patients. A number of
such tools have already received the Food and Drug
Administration clearance, but clinical studies are required to
demonstrate their clinical utility in the postsurgical setting [3,7].
A recent systematic review identified 9 studies assessing the
effect of continuous vital signs monitoring on general wards
[8]. The authors found no evidence of a marked reduction in
intensive care unit transfers or other adverse events with
continuous monitoring but recognized heterogeneous methods,
study populations, and outcome measures. Efficient,
well-designed pilot studies are vital to ensure the robust design
and implementation of large-scale clinical trials [9].
This study aims to evaluate whether continuous remote vital
signs monitoring is a practical way of monitoring surgical
patients outside of the critical care setting and whether its use
is acceptable to patients. The pilot data will be used to inform
a further definitive trial to optimize recruitment, treatment
compliance, and follow-up protocols.
Methods
Study Design
The study was designed as a pilot cluster-randomized,
prospective, parallel-group, controlled single-center pilot study,
comparing remote continuous vital signs monitoring and
intermittent monitoring with intermittent monitoring alone.
Ethical approval was granted on November 30, 2016, by the
Yorkshire & The Humber—Bradford Leeds Research Ethics
Committee (ref: 16/YH/0426). The study was prospectively
registered on the International Standard Randomised Controlled
Trial Number registry (ISRCTN60999823). No changes were
made to the registered protocol. The trial was performed in
accordance with the Good Clinical Practice guidelines and the
Declaration of Helsinki and is presented according to the
Consolidated Standards of Reporting Trials (CONSORT)
statement principles [10] and the CONSORT-EHEALTH
checklist (Multimedia Appendix 1) [11].
The study population comprised patients admitted to 2 elective
general surgery wards (male and female) at a single tertiary
center in Leeds, United Kingdom. Patients aged ≥18 years who
were able to provide informed consent to participate were
included. Patients with a known allergy to the electrode adhesive
and those with a cardiac pacemaker in situ were excluded.
Patients were approached face-to-face by a research nurse or
clinical fellow as soon as possible after their admission onto
the wards. After consideration of a patient information sheet
(see Multimedia Appendix 2), participants gave informed
consent to enter the study.
Randomization
Consenting participants were allocated to one of the two
monitoring arms for the length of their admission, according to
the ward bay they were first arbitrarily admitted to. Each ward
has 4 bays, containing 6 beds each.
Of the 4 bays on each ward, 3 were randomly allocated to one
of the monitoring arms; 2 bays were allocated to receive the
patch and one to receive usual intermittent monitoring. Each
bay was independently block randomized to an intervention
arm by the primary investigator (CD) using Web-based software:
Sealed Envelope [12].
The 2 remaining bays (one on each ward) could not be
randomized because they did not have the required hardware
installed. Patients in these bays were therefore allocated to
receive usual intermittent monitoring alone.
The allocation of patients to each bay was performed by hospital
bed managers, who were independent of the trial and unaware
of the bay allocations. Owing to the nature of the intervention,
neither patients nor their nurses were blinded to the allocated
monitoring arm.
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Control
All patients in the study received usual intermittent vital signs
monitoring. In our institution, this is the National Early Warning
Score, which involves intermittent manual charting of vital signs
and the calculation of a combined score, indicating the patient’s
status. The control arm received intermittent monitoring alone.
For postoperative patients, this typically consisted of an hourly
recording of blood pressure, pulse, temperature, respiratory rate,
and oxygen saturation until the patient's condition was stable
when the frequency of observations was decreased to 2 hourly
and, then, 4 hourly. For patients not undergoing an operation,
the frequency of monitoring was tailored to their condition.
Intervention
Patients admitted to an intervention bay received usual
intermittent monitoring, in addition to continuous vital signs
monitoring through the SensiumVitals (Sensium, Abingdon,
United Kingdom) system. This system consists of a Conformité
Européene–marked wireless patch (Figure 1) worn on the chest
of a patient, which continuously monitors heart rate, respiratory
rate, and temperature. The data are transmitted wirelessly every
2 minutes to a central monitoring station or a mobile device
carried by the patient’s nurse. The nurse is alerted when there
is any deviation from preset physiological norms. The alert
prompts an acknowledgment of the notification, after which
nurses are free to act according to their clinical discretion.
Reminders were sent every 14 minutes until acknowledgment,
and levels of engagement were monitored through daily ward
visits. All other clinical care remained as normal in the
intervention group.
The monitoring system was set up in the wards over a period
of 6 weeks, during which a number of stakeholders were
engaged with the project. Early on, permission from the Estates
and Information Technology departments was obtained. The
ceiling-mounted bridges were installed by the hospital Estates
department using existing electrical wiring circuits to ensure
compliance with local policies. The monitoring software was
integrated with the hospital admissions data system so that
patients could easily be added to the remote monitoring system.
All data were stored and retained on the hospital network,
alleviating initial concerns about data security by inheriting all
hospital security procedures and data backup policies.
General surgeons were informed of the project at local audit
meetings so that they would understand potential escalations of
care prompted by the device, although they were not expected
to apply the patches or carry the mobile devices. Nursing staff
were trained face-to-face to use the system over a period of 1
week, after which ad-hoc refresher training was available on
request.
Primary Outcome Measure
The primary outcome measure was time to antibiotics after the
first evidence of sepsis, defined according to a revised consensus
conference definition in 2001 by the presence of a likely source
of infection and ≥2 of the following criteria [13]: (1) temperature
>38.3°C or <36.0°C; (2) tachycardia >90 beats/minute; (3)
tachypnea >20 breaths/minute; (4) partial pressure of carbon
dioxide <4.3 kPa; (5) hyperglycemia (blood glucose >6.6
mmol/L) in the absence of diabetes mellitus; (6) acutely altered
mental status; and (7) white blood cells count>12×109/L or
<4×109/L.
The decision to prescribe antibiotics was usually made by a
junior doctor on the ward, based on local protocols and clinical
discretion. The time to antibiotics was determined by review of
the observations chart, SensiumVitals data, electronic
medications record, and medical notes of patients during their
hospital admission.
Secondary Outcome Measures
The secondary outcome measures were in-hospital mortality,
length of hospital stay, number of admissions to Level II or III
care, and readmission to hospital within 30 days of discharge.
Patient Acceptability and Compliance
Patient compliance was determined by the number of patients
not wearing a patch for at least 5 days. To assess the
acceptability, patients in the continuous monitoring group were
asked to complete a short 2-question questionnaire at the bedside
on the day of discharge from hospital. Patients were asked to
rank the comfort and sense of safety they perceived from
wearing the patch on a scale from “Strongly Agree” to “Strongly
Disagree.”
Figure 1. The SensiumVitals patch. Photograph used with permission from Sensium (Abingdon, United Kingdom).
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Data Collection
The data collection was performed daily by a research nurse
and a clinical fellow. This allowed any harms or benefits to be
collected in real time. The data were taken from the clinical
records made by patients’ usual care teams, including a
succession of junior medical staff on rotation, who were unaware
of the study. The objective methods of collecting the outcome
data minimized the risk of bias. In addition, the predefined
criteria for the outcome measures provided minimal scope for
interpretation of their presence or absence by the data collection
team.
Statistical Analysis
A formal sample size calculation was not possible given the
lack of data surrounding the primary outcome measure; thus,
assumptions were used to calculate an appropriate sample size.
A sample size of 325-625 was suggested as an appropriate target
based on the assumed eligibility rate (90%), consent rate
(30%-50%), and patient turnover (4 patients per bed per calendar
month).
The analysis was on an intention-to-treat basis at the individual
patient level. Each of the outcome measures was summarized
by the intervention or control group using descriptive statistics.
As there was no formal sample size calculation, no statistical
comparison between trial arms was made.
Exploratory Analysis
The primary analysis included only the 6 randomized bays. The
2 nonrandomized bays were included in a separate exploratory
analysis.
Progression Criteria
Although no formal progression criteria were defined in the
protocol, considerations for the progression to a definitive trial
included:
• Recruitment rate (at least 325 patients within the 9-month
recruitment period)
• Protocol adherence (proportion of patients wearing the patch
for at least 5 days)
• Suitability of primary outcome measure to inform the
sample size of a definitive trial.
Results
Principal Results
In this study, 226 patients were randomized between January
and June 2017. Figure 2 presents the patient flowchart, and
Table 1 presents patients’ characteristics.
While 140 patients were allocated to receive continuous
monitoring alongside standard care, 86 patients were randomized
to the control group. A further 124 patients from nonrandomized
bays were included in the exploratory analysis.
Two patients in the control arm (both from randomized bays)
were given the continuous monitoring intervention at the request
of the direct care team.
Overall, 73% (257/350) of patients underwent a surgical
intervention during their admission; these were mostly colorectal
resections (n=132), stoma formations (n=23), stoma reversals
(n=12), hernia repairs (n=20), and other colorectal laparotomies,
including fistula exploration (n=23). Less common procedures
were hepatobiliary (n=14), urological (n=9), appendicectomy
(n=7), and abdominal wall repair (n=5). Of note, 8 procedures
were classified as Other.
A similar number of complications and sepsis events occurred
across both arms of the study (see Multimedia Appendix 3),
indicating that both groups had similar baseline risk factors.
One patient died of alcoholic liver disease during their
participation in the study. This patient was allocated to receive
continuous monitoring.
Primary Outcome Measure
Table 2 summarizes the main results of the study. In the
intervention arm, 17.1% (24/140) of patients experienced a
sepsis event; this figure was 14% (12/86 patients) in the control
arm. Of 36 sepsis events recorded in randomized bays, there
were sufficient data to analyze the time to antibiotics in 34 cases.
The average time from the first evidence of sepsis to the first
administration of antibiotics was 626 minutes in the intervention
group (n=22, 95% CI 431.7-820.3 minutes). The average time
to antibiotics in the control group was 1012.8 minutes (n=12,
95% CI 425.0-1600.6 minutes; Figure 3). Of 36 sepsis events,
34 cases were triggered by derangements in the heart rate,
respiratory rate, or temperature—heart rate alone (n=1);
temperature alone (n=1); heart rate and temperature (n=23);
respiratory rate and temperature (n=2); heart rate, respiratory
rate, and temperature (n=7); and unknown (n=2).
Secondary Outcome Measures
There were very few inpatient deaths (n=1) and admissions to
level II/III care (n=5) across both study arms. The length of
hospital stay was on average 1.3 days shorter in patients who
had continuous monitoring (13.3 days, 95% CI 11.3-15.3 days
vs 14.6 days, 95% CI 11.5-17.7 days). The rate of readmissions
within 30 days of discharge was lower in the continuous
monitoring group (11.4%, 95% CI 6.16-16.7 vs 20.9, 95% CI
12.3-29.5; Figure 3).
Exploratory Analysis
When the 2 nonrandomized bays were analyzed alongside the
6 randomized bays, the results were very comparable with
narrower CIs (see Multimedia Appendix 3).
Patient Acceptability and Compliance
Overall, 41% (58/140) patients in the continuous monitoring
group returned a short questionnaire; the results are shown in
Figure 4. The majority of patients found the patch to be
comfortable (47/57, 82%) and reported feeling safer while
wearing the patch (46/56, 82%).
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Figure 2. The Consolidated Standards of Reporting Trials flow diagram for the trial.
Patients in the continuous monitoring group wore the patch for
an average of 5 (range: 1-24) days. Of 142 patients who wore
the monitoring patch, 34 had the continuous monitoring
discontinued early (Figure 2); 23 of these were at patient request.
Two patients developed a rash under the electrodes, 18 patients
found it itchy or bothersome, and 3 patients did not offer a
reason for removing the patch.
Progression Criteria
In the pilot trial, 350 patients were recruited within 7 months,
which is well within the recruitment target. Adherence to
protocol was acceptable; 75.7% (106/140) of patients in the
intervention arm wore the patch for at least 5 days.
The low rate of sepsis events across both arms of the study has
meant that the CIs around the mean time to antibiotics are wide,
and it has not been possible to accurately estimate the
intercluster correlation coefficient for this endpoint from the
study data. As such, it is unlikely that the time to antibiotics in
cases of sepsis is a suitable outcome measure to inform the
sample size of a definitive trial using the same protocol.
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Table 1. Baseline patients’ characteristics.
Intermittent monitoring alone
(n=86)
SensiumVitals + intermittent monitoring
(n=140)
Characteristics
39 (45.4)76 (54.3)Males, n (%)
47 (54.6)64 (45.7)Females, n (%)
63.7, 21-9265.2, 24-94Age (years), mean, range
American Society of Anaesthesiologists score for preoperative functional status, n (%)
9 (10.5)9 (6.4)1
35 (40.7)62 (44.3)2
22 (25.6)42 (30.0)3
3 (3.5)3 (2.1)4
17(19.8)24 (17.1)>Not documented
44 (51.2)70 (50)Emergency admissions, n (%)
42 (48.8)70 (50)Elective admissions, n (%)
62 (72.1)103 (73.6)Surgical intervention, n (%)
14 (16.3)19 (13.6)Medical outliers, n (%)
Table 2. A summary of outcome measures.
Intermittent monitoring alone
(n=86)
SensiumVitals + intermittent monitoring
(n=140)
Outcome measures
57 (66.3)102 (72.9)Complicationsa, n (%)
5 (5.8)8 (5.7)Major complicationsb, n (%)
12 (14.0)24 (17.1)Sepsis events, n (%)
1012.8 (425.0-1600.6)626.0 (431.7-820.3)Time (min) to antibiotics in cases of sepsisc, mean (95% CI)
Level II or III admissions
2 (2.3)3 (2.1)n (%)
0-5.510-4.5495% CI
14.6 (11.5-17.7)13.3 (11.3-15.3)Length of stay (in days) in hospital, mean (95% CI)
Readmissions
18 (20.9)16 (11.4)n (%)
12.3-29.56.16-16.795% CI
0 (0)1 (0.7)Inpatient deaths, n (%)
aAll.
bClavien-Dindo>2.
cSensiumVitals + intermittent monitoring (n=22); intermittent monitoring alone (n=12)
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Figure 3. Scatter graphs to show mean (x) and 95% CIs between trial arms for time to antibiotics in sepsis, length of hospital stay, and 30-day readmission
rate. NEWS: National Early Warning Score.
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Figure 4. Patient responses to the questionnaire.
Discussion
In this single-center, randomized controlled pilot trial, surgical
patients with evidence of sepsis tended to receive antibiotics
faster if they received continuous vital signs monitoring
compared with those receiving usual intermittent monitoring
alone. Patients receiving continuous vital signs monitoring had
a shorter average length of hospital stay and were less likely to
require readmission within 30 days of discharge. Patients found
the monitoring device to be acceptable in terms of comfort and
perceived safety.
The findings must be interpreted within the limitations of the
study. A formal sample size calculation was not possible given
the lack of data surrounding the primary outcome measure, and
so the findings were limited to descriptive statistics; no formal
statistical comparison was possible [14]. Although the wide,
overlapping CIs suggest that a statistically significant difference
between the 2 groups is unlikely, with a larger sample size and
increased study power, it is possible that the observed trends
might become statistically significant. In addition, the relatively
small number of sepsis cases means there is likely to be an
imbalance in prerandomization variables, which would require
an adjustment in a formal analysis.
There were very few cases of inpatient mortality or admission
to level II/III care, making comparisons between the monitoring
arms difficult. One explanation for this low event rate is that
the population contained a high proportion of low-risk
patients—medical outliers and those who did not undergo
surgery during their admission. A more striking effect might be
evident in a higher-risk population.
The limitations of the randomization technique must also be
considered. Ideally, the study data would have been analyzed
at the cluster level, but small numbers of patients within each
bay necessitated analysis at the individual level. The
cluster-randomization methodology led to differences in the
baseline demographics of the treatment arms. One of the female
bays allocated to receive continuous monitoring had a
proportionally lower turnover of patients than the other bays.
This led to an imbalance in the male:female ratio between the
2 arms. The fact that the control arm was, on average, 1.5 years
younger than the treatment arm may have conferred an
advantage to this group.
The potential benefits of continuous monitoring may have been
underestimated in this study owing to the exposure to the patch
in the intervention arm. Nearly a quarter of the patients who
were allocated to receive continuous monitoring did not wear
the patch for their entire admission; however, this may reflect
what can be truly expected in the clinical environment. The
patient-reported acceptability of the device was high in the
questionnaire results. This result may be subject to selection
bias. A number of patients were missed when they were
discharged from hospital outside normal working hours, and
enthusiastic patients may have been more likely to complete
the questionnaire.
There were other challenges to implementing the technology.
There was initially an unacceptably high number of alerts sent
to nursing staff; these were reduced by 90% by adjusting the
alarm thresholds to more clinically appropriate levels and
increasing the intervals between reminder alerts. Engagement
with the new system varied between nursing staff but was aided
by support from senior ward nurses. Engagement was further
increased with the implementation of changes suggested by the
nursing staff themselves such as smaller devices and louder
alert tones.
There are few clinical evaluations of continuous vital signs
monitoring in the literature [8]. The preponderance of
observational studies means that causal associations between
interventions and patient outcomes have to be interpreted with
care. The 3 largest randomized controlled trials of continuous
monitoring report conflicting results, illustrating the difficulties
in evaluating such complex interventions. The potential benefit
of the additional monitoring may be negated by inadequacies
in other areas, such as staffing levels, escalation protocols, and
nursing compliance [15]. Demonstrating clinical benefit will
likely require large, well-controlled studies in high-risk
populations to find significant differences in clinical outcomes
such as critical care admissions. This is important as these
systems are not without financial cost. System prices are around
US $1500, and the cost of disposable patches varies [7]. Further
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research is required to determine with certainty whether
continuous postoperative monitoring offers a significant benefit
over intermittent monitoring and can be justified for routine
care in terms of cost-effectiveness.
In conclusion, this study has demonstrated the practicability
and acceptability of implementing a remote continuous
monitoring system in the general surgical ward setting. There
is a trend toward clinical benefit. The findings of this study will
be used to inform the protocols for further evaluations.
Follow-up studies should be individually randomized and
stratified to minimize the baseline differences between the 2
treatment arms and include a high-risk population with a high
rate of adverse events. Furthermore, rare outcomes, such as
mortality, should be avoided in preference of endpoints that are
common to all participants such as the length of hospital stay.
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